Search results
Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
Zacks via Yahoo Finance· 22 hours agoThese include innovative immuno-oncology combinations, including Keytruda with TIGIT, LAG3 and...
Is Johnson & Johnson Stock A Better Pick Over Merck?
Forbes· 1 day agoAlthough Merck trades at a higher valuation of 5.5x trailing revenues, compared to 4.2x for J&J, we think that this valuation gap will likely narrow over...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 20 hours agoMeanwhile, Moderna is expanding its efforts in cancer treatment. The company is partnered with Merck...
Off the news: New dengue vaccine eyed as cases grow | Honolulu Star-Advertiser
Honolulu Star-Advertiser· 1 day agoWith a state of emergency in Puerto Rico, where mosquito-spread dengue fever is endemic, and two cases of travel-related dengue fever reported in Hawaii last month, a push is growing for U.S ...
Merck Expands Access to High-Quality Maternal Care for More
3BL CSRwire· 2 days agoMerck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Merck for Mothers, the company’s global maternal health initiative ...
US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine
Reuters· 22 hours ago, opens new tab said on Tuesday the U.S. Food and Drug Administration (FDA) has declined to approve...
The 3 Most Undervalued Healthcare Stocks to Buy in May 2024
InvestorPlace· 5 days agoA commonly used strategy for investing is sector rotation. A good example is the flow of funds into...
The doctor behind the next big thing in cancer treatment
CNN via Yahoo News· 6 days agoDr Catherine Wu’s research has laid the scientific foundation for the development of cancer vaccines...
Tri-Cities doctor fined after prescribing ivermectin for COVID. 2nd physician charged
Tri-City Herald· 4 days agoA Tri-Cities doctor has been fined $5,000 and ordered to take continuing education classes after he prescribed ivermectin for treatment or prevention of COVID-19. The Washington Medical Commission ...
Lula’s progress plan for Brazil: A year on
Pharmaceutical Technology via Yahoo Finance· 2 days agoGlobalData, the parent company of...strategic asset”, sector association Sindusfarma is highlights Brazil’s role in global efforts to research and...
